JP Morgan Healthcare Conference Roundup: Day One | GenomeWeb

By Edward Winnick and Tony Fong

SAN FRANCISCO (GenomeWeb News) – A busy first day of the 29th Annual JP Morgan Healthcare Conference wrapped up with several firms in the molecular tools and diagnostics industries making their pitches to investors.

Many firms talked about new markets and new products, either recently introduced or on the way, as key revenue drivers. Below are brief summaries taken from some of the firm's presentations and breakout sessions.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.